Posted in:Legal District Judge Dismisses Amgen’s Declaratory Judgment Suit Over Avastin® Biosimilar By D. Lawson Allen February 7, 2018 Comments are off On February 2, 2018, U.S. District Judge George H. Wu granted Genentech’s motion to dismiss a complaint brought by Amgen in the Central... Read more Tagged with: Amgen, Avastin®, bevacizumab, bevacizumab-awwb, BPCIA, Genentech, Mvasi http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus